Portfolio company
StemoniX
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This deep-tech company develops human stem cell-derived organoid platforms for pharmaceutical and biotechnology customers to conduct drug discovery and toxicity screening.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Stemnovate
This company develops human cell-based platforms for drug discovery and toxicity testing to support pharmaceutical firms and research institutions.
Cellbox Labs
This company develops automated organ-on-chip platforms for pharmaceutical firms to perform precise drug discovery and testing without using animal models.
Techbio 2.0
This company develops induced pluripotent stem cell models and artificial intelligence platforms to provide predictive drug discovery data for pharmaceutical and biotechnology researchers.
iOrganBio
This company develops an artificial intelligence-guided manufacturing platform to produce engineered human cells and organoids for biopharmaceutical researchers and clinical partners.
Stately Bio
This company develops machine learning imaging platforms and stem cell-derived therapies for biopharmaceutical researchers and clinical institutions.
Cytochroma
This company manufactures genetically diverse stem cell-derived mini-organs to provide animal-free drug safety and efficacy testing for pharmaceutical and biotechnology organisations.
Insitro
This deep-tech company uses machine learning and genomic data to develop therapeutic drugs for patients with various human diseases.
Hesperos
This company develops multi-organ microchips for pharmaceutical researchers to test drug efficacy and safety without using animals.
